Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) shares were down 2.4% during trading on Friday . The stock traded as low as $1.91 and last traded at $1.99. Approximately 9,158 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 1,388,685 shares. The stock had previously closed at $2.04.
Hillstream BioPharma Stock Performance
The stock’s 50-day simple moving average is $2.62 and its two-hundred day simple moving average is $2.25. The stock has a market cap of $34.99 million, a price-to-earnings ratio of -2.76 and a beta of 3.08.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Featured Stories
- Five stocks we like better than Hillstream BioPharma
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Insider Buying Explained: What Investors Need to Know
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Profitably Trade Stocks at 52-Week Highs
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
